These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29489059)

  • 21. Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter Cohort.
    Hauser A; Santos-Hoevener C; Meixenberger K; Zimmermann R; Somogyi S; Fiedler S; Hofmann A; Bartmeyer B; Jansen K; Hamouda O; Bannert N; Kuecherer C
    PLoS One; 2014; 9(6):e98038. PubMed ID: 24892795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.
    Shah NS; Duong YT; Le LV; Tuan NA; Parekh BS; Ha HTT; Pham QD; Cuc CTT; Dobbs T; Tram TH; Lien TTX; Wagar N; Yang C; Martin A; Wolfe M; Hien NT; Kim AA
    AIDS Res Hum Retroviruses; 2017 Jun; 33(6):546-554. PubMed ID: 28193090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda.
    Longosz AF; Serwadda D; Nalugoda F; Kigozi G; Franco V; Gray RH; Quinn TC; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2014 Apr; 30(4):339-44. PubMed ID: 24083837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma.
    Schlusser KE; Pilcher C; Kallas EG; Santos BR; Deeks SG; Facente S; Keating SM; Busch MP; Murphy G; Welte A; Quinn T; Eshleman SH; Laeyendecker O
    PLoS One; 2017; 12(2):e0172283. PubMed ID: 28231277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay.
    Longosz AF; Mehta SH; Kirk GD; Margolick JB; Brown J; Quinn TC; Eshleman SH; Laeyendecker O
    AIDS; 2014 May; 28(8):1227-32. PubMed ID: 24513567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimating HIV incidence in the Akwa Ibom AIDS indicator survey (AKAIS), Nigeria using the limiting antigen avidity recency assay.
    Negedu-Momoh OR; Balogun O; Dafa I; Etuk A; Oladele EA; Adedokun O; James E; Pandey SR; Khamofu H; Badru T; Robinson J; Mastro TD; Torpey K
    J Int AIDS Soc; 2021 Feb; 24(2):e25669. PubMed ID: 33619853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.
    Duong YT; Qiu M; De AK; Jackson K; Dobbs T; Kim AA; Nkengasong JN; Parekh BS
    PLoS One; 2012; 7(3):e33328. PubMed ID: 22479384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A top scoring pairs classifier for recent HIV infections.
    Chen A; Laeyendecker O; Eshleman SH; Monaco DR; Kammers K; Larman HB; Ruczinski I
    Stat Med; 2021 May; 40(11):2604-2612. PubMed ID: 33660319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Early Antiretroviral Treatment Initiation on Performance of Cross-Sectional Incidence Assays.
    Klock E; Mwinnya G; Eller LA; Fernandez RE; Kibuuka H; Nitayaphan S; Kosgei J; Moore RD; Robb M; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2020 Jul; 36(7):583-589. PubMed ID: 32295382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence.
    Moyo S; LeCuyer T; Wang R; Gaseitsiwe S; Weng J; Musonda R; Bussmann H; Mine M; Engelbrecht S; Makhema J; Marlink R; Baum MK; Novitsky V; Essex M
    AIDS Res Hum Retroviruses; 2014 Jan; 30(1):29-36. PubMed ID: 23937344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D.
    Longosz AF; Morrison CS; Chen PL; Brand HH; Arts E; Nankya I; Salata RA; Quinn TC; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2015 Apr; 31(4):421-7. PubMed ID: 25317854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of an HIV recent infection testing algorithm with serological assays among men who have sex with men in Mexico.
    Karatzas-Delgado EF; Ruiz-González V; García-Cisneros S; Olamendi-Portugal ML; Herrera-Ortiz A; López-Gatell H; González-Rodríguez A; Sánchez-Alemán MA
    J Infect Public Health; 2020 Apr; 13(4):509-513. PubMed ID: 31813835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decision tree for accurate infection timing in individuals newly diagnosed with HIV-1 infection.
    Verhofstede C; Fransen K; Van Den Heuvel A; Van Laethem K; Ruelle J; Vancutsem E; Stoffels K; Van den Wijngaert S; Delforge ML; Vaira D; Hebberecht L; Schauvliege M; Mortier V; Dauwe K; Callens S
    BMC Infect Dis; 2017 Nov; 17(1):738. PubMed ID: 29187159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx.
    Huik K; Soodla P; Pauskar M; Owen SM; Luo W; Murphy G; Jõgeda EL; Kallas E; Rajasaar H; Avi R; Masciotra S; Lutsar I;
    PLoS One; 2019; 14(5):e0217048. PubMed ID: 31125356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Comparison of South African National HIV Incidence Estimates: A Critical Appraisal of Different Methods.
    Rehle T; Johnson L; Hallett T; Mahy M; Kim A; Odido H; Onoya D; Jooste S; Shisana O; Puren A; Parekh B; Stover J
    PLoS One; 2015; 10(7):e0133255. PubMed ID: 26230949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the Performance of Three Biomarker Assays for Recent HIV Infection Using a Well-Characterized HIV-1 Subtype C Incidence Cohort.
    Gonese E; Kilmarx PH; van Schalkwyk C; Grebe E; Mutasa K; Ntozini R; Parekh B; Dobbs T; Duong Pottinger Y; Masciotra S; Owen M; Nachega JB; van Zyl G; Hargrove JW
    AIDS Res Hum Retroviruses; 2019 Jul; 35(7):615-627. PubMed ID: 30938164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa.
    Huerga H; Shiferie F; Grebe E; Giuliani R; Farhat JB; Van-Cutsem G; Cohen K
    BMC Infect Dis; 2017 Sep; 17(1):653. PubMed ID: 28969607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Window Into the HIV Epidemic from a South African Emergency Department.
    Hansoti B; Stead D; Eisenberg A; Mvandaba N; Mwinnyaa G; Patel EU; Parrish A; Reynolds SJ; Redd AD; Fernandez R; Rothman RE; Laeyendecker O; Quinn TC
    AIDS Res Hum Retroviruses; 2019 Feb; 35(2):139-144. PubMed ID: 30215268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a sensitive/less-sensitive testing algorithm using the 3A11-LS assay for detecting recent HIV seroconversion among individuals with HIV-1 subtype B or E infection in Thailand.
    Parekh BS; Hu DJ; Vanichseni S; Satten GA; Candal D; Young NL; Kitayaporn D; Srisuwanvilai LO; Rakhtam S; Janssen R; Choopanya K; Mastro TD
    AIDS Res Hum Retroviruses; 2001 Mar; 17(5):453-8. PubMed ID: 11282014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assay.
    Keating SM; Rountree W; Grebe E; Pappas AL; Stone M; Hampton D; Todd CA; Poniewierski MS; Sanchez A; Porth CG; Denny TN; Busch MP;
    PLoS One; 2019; 14(9):e0222290. PubMed ID: 31525218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.